BlackRock’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-75,753
Closed -$25K 5540
2023
Q1
$25K Sell
75,753
-145
-0.2% -$48 ﹤0.01% 5142
2022
Q4
$54.6K Sell
75,898
-185
-0.2% -$133 ﹤0.01% 5121
2022
Q3
$92K Sell
76,083
-287
-0.4% -$347 ﹤0.01% 5112
2022
Q2
$91K Buy
76,370
+848
+1% +$1.01K ﹤0.01% 5171
2022
Q1
$163K Buy
75,522
+135
+0.2% +$291 ﹤0.01% 5076
2021
Q4
$113K Buy
75,387
+299
+0.4% +$448 ﹤0.01% 5169
2021
Q3
$219K Buy
75,088
+319
+0.4% +$930 ﹤0.01% 4901
2021
Q2
$247K Sell
74,769
-30,854
-29% -$102K ﹤0.01% 4784
2021
Q1
$397K Buy
105,623
+2,173
+2% +$8.17K ﹤0.01% 4575
2020
Q4
$366K Buy
103,450
+887
+0.9% +$3.14K ﹤0.01% 4314
2020
Q3
$674K Sell
102,563
-1,181
-1% -$7.76K ﹤0.01% 4106
2020
Q2
$772K Buy
103,744
+2,971
+3% +$22.1K ﹤0.01% 4028
2020
Q1
$474K Sell
100,773
-11
-0% -$52 ﹤0.01% 3994
2019
Q4
$1.3M Sell
100,784
-39
-0% -$503 ﹤0.01% 3863
2019
Q3
$1.06M Sell
100,823
-25,767
-20% -$271K ﹤0.01% 3906
2019
Q2
$2.15M Sell
126,590
-160,835
-56% -$2.73M ﹤0.01% 3704
2019
Q1
$9.69M Sell
287,425
-6,126
-2% -$206K ﹤0.01% 3106
2018
Q4
$8.57M Sell
293,551
-49,568
-14% -$1.45M ﹤0.01% 3157
2018
Q3
$21.1M Buy
343,119
+31,880
+10% +$1.96M ﹤0.01% 2821
2018
Q2
$23M Buy
311,239
+84,920
+38% +$6.27M ﹤0.01% 2760
2018
Q1
$14.8M Sell
226,319
-5,098
-2% -$334K ﹤0.01% 2900
2017
Q4
$19.5M Sell
231,417
-3,659
-2% -$308K ﹤0.01% 2775
2017
Q3
$27.2M Buy
235,076
+14,925
+7% +$1.72M ﹤0.01% 2604
2017
Q2
$25.7M Buy
220,151
+53,075
+32% +$6.2M ﹤0.01% 2633
2017
Q1
$20.6M Buy
167,076
+166,819
+64,910% +$20.6M ﹤0.01% 2724
2016
Q4
$35K Buy
257
+18
+8% +$2.45K ﹤0.01% 3026
2016
Q3
$47K Buy
239
+29
+14% +$5.7K ﹤0.01% 2929
2016
Q2
$28K Buy
210
+178
+556% +$23.7K ﹤0.01% 3128
2016
Q1
$3K Buy
32
+11
+52% +$1.03K ﹤0.01% 3375
2015
Q4
$4K Sell
21
-160
-88% -$30.5K ﹤0.01% 3184
2015
Q3
$26K Buy
181
+160
+762% +$23K ﹤0.01% 2210
2015
Q2
$4K Hold
21
﹤0.01% 3121
2015
Q1
$5K Buy
+21
New +$5K ﹤0.01% 3002